Polish Contract Research Organization

Monitoring of phase II - IV clinical trials

Trainings: ICH-GCP, Brillance Academy

Brillance awarded in the Forbes Diamonds 2017 ranking


We are proud to announce that Brillance was awarded in the Forbes Diamonds 2017 ranking.

 

Forbes Diamonds is a ranking of the fastest-growing enterprises in Poland, which have most dynamically increased their value in the last three years.This year’s edition was the tenth one  organised in Poland and it was prepared by editors of Forbes magazine  in cooperation with  the business intelligence company Bisnode Polska. Bisnode Group collected data concerning business entities which submitted reports to the National Court Register in a timely manner in 2015. During the assessment, analysts of Bisnode valuated enterprises according to the Swiss valuation method. Decisive criteria of the ranking involved: company’s financial results, value of assets, payment history and lack of negative legal events.

 

On 18th May 2017 an official Forbes Diamonds Gala was held in Hotel Stary in Krakow. CEO of Brillance, Mr Pawel Dyras, MD, PhD accepted the award on behalf of the company. We are honoured to  hold the title of “Forbes Diamonds 2017” and we are looking forward to new business challenges.

 

 

 

 

http://diamenty.forbes.pl/diamenty-forbesa-dla-najlepszych-firm-z-wojewodztwa-malopolskiego-zdjecia,artykuly,212828,1,1,1.html

News

Brillance attends Partnerships in Clinical Trials Europe 2017

 

Brillance awarded in the Forbes Diamonds 2017 ranking

Brillance attends American Society of Hematology Annual Meeting in San Diego

Brillance is proud to participate in this year edition of American Society of Hematology Annual Meeting in San Diego on December 3-6, 2016.

 

 

CRO Poland

Clinical Trials

Monitoring of Clinical Trials